Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Mindstrong is a virtual mental health platform.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Foresite Capital has invested in 129 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Life Science. The firm invests across 17 different industry categories.
Among tracked funding rounds, Kriya Therapeutics received $320.8M in a Series D round. Foresite Capital's total known invested capital is $15.9B.
Foresite Capital's average investment size is $127.8M across its portfolio of 129 companies.
Recent Foresite Capital portfolio additions include Venatorx Pharmaceuticals, Mindstrong Health, Korsana Biosciences, XinThera, Kriya Therapeutics. These companies were founded in 2020 or later.